sb 206553 has been researched along with Pulmonary Hypertension in 1 studies
SB 206553: a high-affinity 5-HT(2C/2B) antagonist; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with fasudil, a Rho kinase inhibitor, blunted the effects of 5-HT infusion." | 1.37 | Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus. ( Abman, SH; Delaney, C; Gien, J; Grover, TR; Roe, G, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delaney, C | 1 |
| Gien, J | 1 |
| Grover, TR | 1 |
| Roe, G | 1 |
| Abman, SH | 1 |
1 other study available for sb 206553 and Pulmonary Hypertension
| Article | Year |
|---|---|
Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Dose-Response Relationship, Drug; Female; Fe | 2011 |